Naomi F. Rothfield

Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku.

F. Arnett, S. Rich, D. Dantzker, 1992, The American journal of medicine.

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.

W. Earnshaw, J. Senécal, N. Rothfield, 1988, Arthritis and rheumatism.

Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.

Richard W. Martin, S. Jimenez, M. Mayes, 1998, Arthritis and rheumatism.

Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

J. Minta, N. Rothfield, I. Lepow, 1972, The New England journal of medicine.

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

R. Elashoff, R. Elashoff, M. Roth, 2007, American journal of respiratory and critical care medicine.

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

K. E. Schwartz, K. Kalunian, M. Petri, 2004, Arthritis and rheumatism.

An epidemiologic study of households exposed to canine systemic lupus erythematosus.

A. Steinberg, R. Kaslow, N. Zvaifler, 1980, Arthritis and rheumatism.

Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.

R. Elashoff, M. Roth, M. Mayes, 2005, Arthritis and rheumatism.

Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.

W. Earnshaw, J. Senécal, N. Rothfield, 1990, Clinical immunology and immunopathology.

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.

W. Earnshaw, P. D'Arpa, D. Cleveland, 1988, Proceedings of the National Academy of Sciences of the United States of America.